Mentoring Office Hours: Leadership Challenges (January 30)

01/30/2026 10:00 AM - 12:00 PM ET

Admission

Free

Description

Mentoring Office Hours

Leadership Challenges

Friday, January 30, 2026

10 am - 12 pm ET

via Teams

Would you benefit from some advice in the new year? Could you use 40 minutes with an expert Club member to discuss leadership challenges? We’re excited to introduce the opportunity to do just that!

Register for a 40-minute timeslot during our virtual Mentoring Office Hours for a one-on-one conversation on any leadership challenges you face with Richa Poddar! Richa is VP New Product Planning and Medical Affairs at Fog Pharmaceuticals. She has signifiant experience building and leading diverse teams, and is known for fostering a culture of trust, transparency, and accountability.

There are 4 advising slots available; registration is on a first-come, first-served basis. Please register for ONE SESSION ONLY. After you have registered, you will receive a separate email with a brief questionnaire about your goals for the conversation that we will share with Richa before your meeting.

Questions? Curiosities? Please email Edith Onderick-Harvey, Mentorship Co-Chair.

Richa Poddar

As Senior Vice President, Commercial Strategy & Medical Affairs, Richa Poddar, MBS, plays an integral role in achieving our ambitious goal to be a unique creator of life-changing medicines by optimizing the competitive positioning of our portfolio of programs as they are developed for the market. Prior to joining Parabilis Medicines, Richa was the Chief Business and Strategy Officer at Matterhorn BioSciences, a discovery-stage, cell therapy startup. Before joining Matterhorn, Richa worked as the Chief Commercial Officer at Agios Pharmaceuticals. During her six-year tenure at Agios, she played an instrumental role in launching the company’s first rare disease product, PYRUKYND®, as well as its first two oncology products, TIBSOVO® and IDHIFA®. Richa was in charge of shaping the company’s oncology portfolio by providing strong cross-functional and strategic program leadership. She also spearheaded the transition of the company’s oncology assets to Servier. Richa has held various roles in the pharmaceutical industry, including at Amgen, Clovis Oncology, and Genentech/F. Hoffman La-Roche. In these roles, Richa focused on marketing and market analytics for various oncology products, including Herceptin® and Avastin®. Richa completed her B.E. in computer engineering from Pune University and her master’s in biotechnology (MBS) from Keck Graduate Institute in California.